Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Glycaemic control trends in people with type 1 diabetes in Scotland 2004-2016.

Mair C, Wulaningsih W, Jeyam A, McGurnaghan S, Blackbourn L, Kennon B, Leese G, Lindsay R, McCrimmon RJ, McKnight J, Petrie JR, Sattar N, Wild SH, Conway N, Craigie I, Robertson K, Bath L, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network (SDRN) Epidemiology Group.

Diabetologia. 2019 May 18. doi: 10.1007/s00125-019-4900-7. [Epub ahead of print]

PMID:
31104095
2.

The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy.

Seed RI, Taurozzi AJ, Wilcock DJ, Nappo G, Erb HHH, Read ML, Gurney M, Archer LK, Ito S, Rumsby MG, Petrie JL, Clayton A, Maitland NJ, Collins AT.

Sci Rep. 2019 Mar 26;9(1):5120. doi: 10.1038/s41598-019-41379-8.

3.

Correction to: One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort.

Manco M, Mari A, Petrie J, Mingrone G, Balkau B; EGIR-RISC study group.

Diabetologia. 2019 May;62(5):874. doi: 10.1007/s00125-019-4846-9.

PMID:
30899968
4.

Effects on prostate cancer cells of targeting RNA polymerase III.

Petrie JL, Swan C, Ingram RM, Frame FM, Collins AT, Dumay-Odelot H, Teichmann M, Maitland NJ, White RJ.

Nucleic Acids Res. 2019 Mar 1. pii: gkz128. doi: 10.1093/nar/gkz128. [Epub ahead of print]

5.

Excess Cardiovascular Risk in Type 1 Diabetes Mellitus.

Petrie JR, Sattar N.

Circulation. 2019 Feb 5;139(6):744-747. doi: 10.1161/CIRCULATIONAHA.118.038137. No abstract available.

PMID:
30715940
6.

The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study.

McGurnaghan SJ, Brierley L, Caparrotta TM, McKeigue PM, Blackbourn LAK, Wild SH, Leese GP, McCrimmon RJ, McKnight JA, Pearson ER, Petrie JR, Sattar N, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group.

Diabetologia. 2019 Apr;62(4):621-632. doi: 10.1007/s00125-018-4806-9. Epub 2019 Jan 10.

PMID:
30631892
7.

One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort.

Manco M, Mari A, Petrie J, Mingrone G, Balkau B; EGIR-RISC study group.

Diabetologia. 2019 Mar;62(3):544-548. doi: 10.1007/s00125-018-4798-5. Epub 2018 Dec 29. No abstract available. Erratum in: Diabetologia. 2019 May;62(5):874.

8.

Astrocyte HIF-2α supports learning in a passive avoidance paradigm under hypoxic stress.

Leiton CV, Chen E, Cutrone A, Conn K, Mellanson K, Malik DM, Klingener M, Lamm R, Cutrone M, Petrie J 4th, Sheikh J, DiBua A, Cohen B, Floyd TF.

Hypoxia (Auckl). 2018 Nov 8;6:35-56. doi: 10.2147/HP.S173589. eCollection 2018.

9.

Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review.

Boyle JG, Livingstone R, Petrie JR.

Clin Sci (Lond). 2018 Aug 16;132(15):1699-1709. doi: 10.1042/CS20171299. Print 2018 Aug 16. Review.

PMID:
30115742
10.

Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.

Read SH, van Diepen M, Colhoun HM, Halbesma N, Lindsay RS, McKnight JA, McAllister DA, Pearson ER, Petrie JR, Philip S, Sattar N, Woodward M, Wild SH; Scottish Diabetes Research Network Epidemiology Group.

Diabetes Care. 2018 Sep;41(9):2010-2018. doi: 10.2337/dc18-0578. Epub 2018 Jul 12.

PMID:
30002197
11.

Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus.

McAllister DA, Read SH, Kerssens J, Livingstone S, McGurnaghan S, Jhund P, Petrie J, Sattar N, Fischbacher C, Kristensen SL, McMurray J, Colhoun HM, Wild SH.

Circulation. 2018 Dec 11;138(24):2774-2786. doi: 10.1161/CIRCULATIONAHA.118.034986.

12.

Metformin, lipids and atherosclerosis prevention.

Jenkins AJ, Welsh P, Petrie JR.

Curr Opin Lipidol. 2018 Aug;29(4):346-353. doi: 10.1097/MOL.0000000000000532.

PMID:
29878903
13.

Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study.

Siméon S, Massy Z, Højlund K, Lalic K, Porcellati F, Dekker J, Petrie J, Currie G, Balkau B.

BMC Nephrol. 2018 May 31;19(1):124. doi: 10.1186/s12882-018-0918-1.

14.

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT.

Griffin SJ, Bethel MA, Holman RR, Khunti K, Wareham N, Brierley G, Davies M, Dymond A, Eichenberger R, Evans P, Gray A, Greaves C, Harrington K, Hitman G, Irving G, Lessels S, Millward A, Petrie JR, Rutter M, Sampson M, Sattar N, Sharp S.

Health Technol Assess. 2018 Apr;22(18):1-64. doi: 10.3310/hta22180.

15.

Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.

Petrie JR, Guzik TJ, Touyz RM.

Can J Cardiol. 2018 May;34(5):575-584. doi: 10.1016/j.cjca.2017.12.005. Epub 2017 Dec 11. Review.

16.

N-Glycan Profile and Kidney Disease in Type 1 Diabetes.

Bermingham ML, Colombo M, McGurnaghan SJ, Blackbourn LAK, Vučković F, Pučić Baković M, Trbojević-Akmačić I, Lauc G, Agakov F, Agakova AS, Hayward C, Klarić L, Palmer CNA, Petrie JR, Chalmers J, Collier A, Green F, Lindsay RS, Macrury S, McKnight JA, Patrick AW, Thekkepat S, Gornik O, McKeigue PM, Colhoun HM; SDRN Type 1 Bioresource Investigators.

Diabetes Care. 2018 Jan;41(1):79-87. doi: 10.2337/dc17-1042. Epub 2017 Nov 16.

PMID:
29146600
17.

Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012-2014): a population-based observational study.

Walker J, Colhoun H, Livingstone S, McCrimmon R, Petrie J, Sattar N, Wild S; Scottish Diabetes Research Network Epidemiology Group.

Diabetologia. 2018 Jan;61(1):108-116. doi: 10.1007/s00125-017-4478-x. Epub 2017 Oct 26.

18.

Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L.

Diabetes Care. 2017 Dec;40(12):1614-1621. doi: 10.2337/dci17-0043. Epub 2017 Oct 25. Review.

PMID:
29070577
19.

Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L.

Diabetologia. 2017 Dec;60(12):2319-2328. doi: 10.1007/s00125-017-4463-4. Epub 2017 Oct 25. Review.

PMID:
29067486
20.

SGLT2 inhibitors in type 1 diabetes: knocked down, but up again?

Petrie JR.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):841-843. doi: 10.1016/S2213-8587(17)30315-7. Epub 2017 Sep 14. No abstract available.

PMID:
28919060

Supplemental Content

Loading ...
Support Center